Technology Transfer and Supply of Vaccines with FioCruz

Technology transfer and product supply agreements for polio, MMR, Rotavirus and pneumococcal vaccines.

Vaccine Partnership with FioCruz

GlaxoSmithKline has been partnering with Brazil’s Oswaldo Cruz Foundation (FioCruz) since 1985 to manufacture vaccines for public health priorities in Brazil including polio, Haemophilus influenzae type b (Hib), measles, mumps, rubella, rotavirus and, most recently, pneumococcal disease.

To address pneumococcal disease in Brazil, GlaxoSmithKline will provide FioCruz with access to the technology behind its SynflorixTM vaccine which protects against life-threatening pneumonia, meningitis and bacteraemia infections. GlaxoSmithKline will supply SynflorixTM to FioCruz until the technology transfer is completed. The deal benefits both GlaxoSmithKline and FioCruz and is helping to ensure that the annual cohort of 3.5 million babies in Brazil will be protected by GlaxoSmithKline's and Fiocruz vaccines.


  • GlaxoSmithKline (GSK)

    Goods Supplier
    United Kingdom | Staff size: 10,000+

    We are a science-led global healthcare company that researches and develops a broad range of innovative medicines and brands. Our products are used by millions of people around the world,...

  • Brazil Ministry of Health

    Brazil | Staff size: 10,000+

    The Ministry of Health is a body of the Federal Executive Power that is in charge of organizing and outlining public plans and policies oriented to promote, prevent and assist the...

  • Oswaldo Cruz Foundation (Fiocruz)

    Government, Implementing NGO
    Brazil | Staff size: 10,000+

    Fundação Oswaldo Cruz (Oswaldo Cruz Foundation, known as Fiocruz), attached to the Brazilian Ministry of Health in Rio de Janeiro is the most prominent science and technology...

More Resources

Key Information

LocationLatin America and Caribbean, Brazil
  • Start Date 1985